GE Healthcare Tells Investors it s Targeting Leadership in Breast Cancer Dx, Management | GenomeWeb

GE Healthcare wants to be recognized as “the first company to address the overall diagnosis and management of breast cancer.”

GE Healthcare executives made that promise last week in Chicago at an investor’s presentation coinciding with the annual meeting of the Radiological Society of North America.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

An opinion piece in the New York Times urges lawmakers to keep genetic protections in place.

Research funding in Canada is to remain mostly the same, ScienceInsider reports.

In Science this week: random DNA replication errors play role in cancer, and more.

The Bill and Melinda Gates Foundation embarks on an open-access publishing path.